BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38409759)

  • 1. Ureter Metastasis From Colorectal Cancer Revealed on 18 F-FDG PET/CT.
    Zhang J; Yang L; Wei L; Guo Z; Xie P
    Clin Nucl Med; 2024 May; 49(5):478-480. PubMed ID: 38409759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
    Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT Findings of MALT Lymphoma of Ureter.
    He L; Deng Y; Deng Y; Xie H; Zhang W
    Clin Nucl Med; 2022 Sep; 47(9):828-829. PubMed ID: 35930711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer.
    Zhou X; Li Y; Jiang X; Wang X; Chen S; Shen T; You J; Lu H; Liao H; Li Z; Cheng Z
    Front Oncol; 2020; 10():585213. PubMed ID: 33604285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of
    Arslan E; Aksoy T; Gürsu RU; Dursun N; Çakar E; Çermik TF
    Mol Imaging Radionucl Ther; 2020 Feb; 29(1):17-24. PubMed ID: 32079384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac 18F‑FDG uptake and new‑onset rectal cancer.
    Sawaragi K; Okada Y; Aono Y; Yasuoka R; Takayama S; Yao R; Mitsuyama T; Saigusa S; Fujikawa H; Mori T; Hashimoto M; Higashi K; Sakurai H; Tanaka K; Okugawa Y; Tanaka N; Toiyama Y; Okazaki K; Naganuma M
    Oncol Lett; 2023 May; 25(5):197. PubMed ID: 37113403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in liver metastasis lesions after colon radical operation.
    Qiao Y; Li X; Hu Y; Guo P; Liu H; Sun H
    BMC Cancer; 2023 Jun; 23(1):535. PubMed ID: 37308878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraureteral Metastasis From Colon Cancer Mimicking Primary Ureteral Carcinoma on FDG PET/CT.
    Ji X; Dong A; Zhu Y
    Clin Nucl Med; 2024 Jun; ():. PubMed ID: 38861423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of aseptic vascular grafts after endovascular aortic repair on [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Bennett P; Tomas MB; Koch CF; Nichols KJ; Palestro CJ
    World J Radiol; 2023 Aug; 15(8):241-249. PubMed ID: 37662425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
    Sun J; Cui XW; Li YS; Wang SY; Yin Q; Wang XN; Gu L
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7276-7283. PubMed ID: 32706065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG PET/CT features of ureteral metastases from breast cancer: a case report.
    Huang Y; He H; Wei W; Li Q; Long X; Li Y; Chen R; Yi X
    J Int Med Res; 2021 May; 49(5):3000605211014090. PubMed ID: 33990152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study.
    Chen X; Xu X; Chrysikos S; Zhao M; Zhou Y
    Transl Lung Cancer Res; 2022 Sep; 11(9):1926-1935. PubMed ID: 36248335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma.
    Peng Y; Qi W; Luo Z; Zeng Q; Huang Y; Wang Y; Sharma A; Schmidt-Wolf IGH; Liao F
    Front Oncol; 2022; 12():973109. PubMed ID: 36185301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT metabolic parameters and HER2 expression in colorectal cancer.
    Yang Z; Liu S; Sun Y; Xu J; Jiang J; Ma X; Zhang Y; Song S
    Neoplasma; 2021 Jul; 68(4):875-881. PubMed ID: 33998235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of dual-time
    Pahk K; Chung JH; Kim S; Lee SH
    Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined SUVmax and localized colonic wall thickening parameters to identify high-risk lesions from incidental focal colorectal
    Xu W; Li H; Guo Z; Zhang L; Zhang R; Zhang L
    Front Oncol; 2022; 12():972096. PubMed ID: 36033516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Investigation of the Relationship Between
    Kandemir O; Demir F
    Curr Radiopharm; 2024; 17(1):111-116. PubMed ID: 37644744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
    Peng J; He Y; Xu J; Sheng J; Cai S; Zhang Z
    Colorectal Dis; 2011 Nov; 13(11):e374-8. PubMed ID: 21831098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.